Broker Notes, Comments and Analysis

Broker notes, analysis and comments

Fidelity Japan Trust: Favourable G7 2023 economic outlook for Japan

The January 2023 IMF World Economic Outlook update has reiterated, once again, the relative appeal of Japan compared with the other major developed economies. In particular, the IMF is forecasting..

Pennant International Group “Look at the leap in gross margins” Analyst Nick Spoliar

Pennant International Group plc (LON:PEN), is the subject of conversation when we caught up with Nick Spoliar, Analyst at WH Ireland. Pennant International Group plc has provided a trading update..

ICG Enterprise Trust: 3Q’23: continued growth and resilience

ICG Enterprise Trust plc (LON:ICGT) reported another strong quarter, with an NAV per share total return of 3.6% in 3Q’22 and a portfolio return of 13.8% (local currency) for the..

Union Jack Oil “continue to indicate a robust financial performance” Shore Capital

Union Jack Oil (LON:UJO) is the topic of conversation when DirectorsTalk caught up with Craig Howie, Analyst at Shore Capital. Craig, Union Jack Oil announced landmark revenues of US$13m have..

Nanoco Group latest 2023 research from Turner Pope

Nanoco Group plc (LON:NANO) has confirmed a transformative outcome for the Group in terms of its signing of final definitive agreements (collectively the ‘Settlement’) with Samsung for US$150m (c.£125m) to..

CentralNic Group revenue and adjusted EBITDA ahead of Edison forecasts

CentralNic Group plc (LON:CNIC) FY22 update confirmed accelerating momentum towards the end of the year, with revenue and adjusted EBITDA ahead of our forecasts, which we raised on 21 December...

Accrol Group thoughts from Liberum Analyst Anubhav Malhotra (LON:ACRL)

Accrol Group Holdings plc (LON:ACRL) is the topic of conversation when Liberum’s Analyst Anubhav Malhotra caught up with DirectorsTalk for an exclusive interview. Q1: What are the highlights from the..

Advanced Oncotherapy: Understanding the significance of 230MeV

Advanced Oncotherapy plc (LON:AVO) goal is to deliver an affordable and novel PT system, called LIGHT, based on state-of-the-art technology, developed originally at the world-renowned CERN. The complex assembly of..

Apax Global Alpha: Making pearls out of oysters

Apax Global Alpha Limited (LON:APAX) (AGA) core is the investment in the Apax Private Equity Funds, which, in turn, target the acquisition of private companies, whose performance is then transformed..

Echo Energy infrastructure upgrades clearly starting to benefit production (LON: ECHO)

Echo Energy Plc (LON:ECHO), the Latin American focused energy company, has provided an operational update regarding its Santa Cruz Sur assets, onshore Argentina, for the quarter ended 31 December 2022...

Shield Therapeutics: Positioned for growth and profitability

Shield Therapeutics plc (LON:STX) is a commercial-stage pharma company delivering specialty products that address patients’ unmet medical needs, with an initial focus on iron deficiency (ID). Since its US launch..

Volta Finance: R&A shining light on 20%+ IRR base-case scenarios

In our note, Cash is king and the king is rocking and rolling, published on 16 September 2022, we examined Volta Finance Ltd (LON:VTA) success in generating cashflows at near-record..

Fidelity China Special Situations: Government controls put into perspective

In this note, we give our view on Chinese government policies, putting into perspective their objectives, the potential risks and upsides, and how fundamentals and sentiment may be affected. We..

Surface Transforms: Major OEM 10 order, OEM 8 delay resolved

Surface Transforms plc (LON:SCE) The 24 November OEM 10 order raised the order book 50%. Even before this, it had quadrupled in under two years. This latest £100m lifetime (six-year)..

Serinus Energy “well positioned to generate significant cash flows” says Arden Analyst

Serinus Energy plc (LON:SENX WSE:SEN) is the topic of conversation when Dan Slater, Analyst at Arden Partners caught up with DirectorsTalk Interviews. Serinus Energy plc has announced that the CTF-04..

International Biotechnology Trust: Low FDA activity may drive further M&A

International Biotechnology Trust plc (LON:IBT) was established in 1994 to provide institutional and retail investors with the opportunity to participate in global biotechnology and life science companies, from venture-stage early..

Valeura Energy US$260mm operating cash flow forecasted in 2023 from expansion says Stephane Foucaud (TSX:VLE)

Valeura Energy Inc (TSX:VLE) announced on 6 December 2022 the acquisition of the Thailand upstream oil producing portfolio of Busrakham Oil and Gas Ltd, a subsidiary of Mubadala Energy. DirectorsTalk interviewed Stephane Foucaud,..

Cerillion plc – Resilience, growth and revenue visibility raises Singer Capital’s target price (LON: CER)

Cerillion plc (LON:CER) published their annual results for the 12 months ended 30 September 2022. DirectorsTalk caught up with Harold Evans, Senior Research Analyst, TMT at Singer Capital Markets for..

Oakley Capital Investments: Evolution of the high-growth drivers in 2023

In this note, we explore the factors that have driven the market-beating 22% YTD 2022 NAV growth, the 15% growth we expect in 2023 and the 35% NAV discount. In..

Cerillion plc seizes huge market with record results, back order book and pipeline (Liberum Q&A)

Cerillion plc (LON:CER) is the topic of conversation when Darren Turgel, DirectorsTalk CEO, caught up with Ciaran Donnelly, Technology & Media Analyst at Liberum Equity Research, to discuss Cerillion’s annual results for..

Search

Funds

Broker Notes, Comments and Analysis

Search

Funds

Broker Notes, Comments and Analysis

FTSE 100

Funds